Tag: Medical Regulation ⋅ Page 1

Professor Lietzan Files Amicus Brief with U.S. Supreme Court in Patent Case

Professor Lietzan recently filed an amicus brief in the United States Supreme Court, in a closely-watched case involving patent litigation under the Biologics Price Competition and Innovation Act (BPCIA). The appellate court concluded that biosimilar applicants may elect not to comply with the information exchange provisions laid out in the statute, effectively opting out of the statutory premarket patent litigation…